Ligand validation:4L5J

HSX: 5-O-phosphono-alpha-D-ribofuranose

HSX is a Ligand Of Interest in 4L5J designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4L5J_HSX_B_401	75%	44%	0.133	0.966	1.23	0.93	1	1	0	0	100%	1
4L5J_HSX_C_401	70%	45%	0.156	0.976	1.23	0.92	1	1	0	0	100%	1
4L5J_HSX_A_501	66%	43%	0.162	0.968	1.24	0.96	1	1	0	0	100%	1
4L5J_HSX_D_401	56%	45%	0.186	0.958	1.27	0.88	1	-	1	0	100%	1
4L51_HSX_B_401	95%	0%	0.071	0.973	6.07	3.26	10	8	0	0	100%	1
1ZN7_HSX_A_506	98%	54%	0.065	0.987	0.79	0.97	-	-	1	0	100%	0.5
9DT7_HSX_B_302	96%	67%	0.063	0.971	0.48	0.79	-	1	0	0	100%	0.65
4LRF_HSX_A_406	83%	56%	0.098	0.956	0.61	1.06	-	1	0	0	100%	0.75
3MBI_HSX_D_286	76%	43%	0.14	0.976	0.82	1.39	-	2	1	0	100%	0.7493

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.